Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-011773
Filing Date
2025-05-02
Accepted
2025-05-02 16:08:05
Documents
1
Period of Report
2025-05-01

Document Format Files

Seq Description Document Type Size
1 form4-05022025_080502.html 4  
1 form4-05022025_080502.xml 4 5931
  Complete submission text file 0001415889-25-011773.txt   7639
Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SAN DIEGO CA 92130 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Issuer) CIK: 0001159036 (see all company filings)

EIN.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address
Krishnan Mahesh (Reporting) CIK: 0001866746 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32335 | Film No.: 25908493